Inhibition of cytochemical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type I. 1982

N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen

Despite the high circulating levels of immunoreactive PTH in patients with pseudohypoparathyroidism type I (PSPI) the levels of bioactive PTH (bioPTH) have been found to be close to the normal range. To elucidate this dissociation, we have studied the recovery of the biological activity of bovine PTH added to the plasma of patients with either PSPI, or with hypoparathyroidism (PTX), primary hyperparathyroidism (HPT) or of normal subjects. In PSPI (n = 10) the recovery of biological activity was 5.6% +/- 3.6 (mean +/- SEM) whereas in PTX (n = 7), in HPT (n = 4) and in normal subjects (n = 8) it was 79% +/- 5, 75% +/- 9 and 68% +/- 4, respectively. In another PSPI patient, who had undergone total parathyroidectomy, bioPTH was undetectable but the recovery from the plasma of added PTH was 84%. Thus we have found inhibition of PTH bioactivity by plasma of PSPI patients which was absent after parathyroidectomy.

UI MeSH Term Description Entries
D006961 Hyperparathyroidism A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.
D007011 Hypoparathyroidism A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone. Idiopathic Hypoparathyroidism,Hypoparathyroidism, Idiopathic
D008297 Male Males
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D011547 Pseudohypoparathyroidism A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN. Albright Hereditary Osteodystrophy,PHPIa,Albright Hereditary Osteodystrophy with Multiple Hormone Resistance,PHD Ib,PHD1b,PHP Ia,Pseudohypoparathyroidism Type 1B,Pseudohypoparathyroidism, Type Ia,Pseudohypoparathyroidism, Type Ib,Hereditary Osteodystrophy, Albright,Osteodystrophy, Albright Hereditary,Pseudohypoparathyroidism Type 1Bs,Pseudohypoparathyroidisms,Pseudohypoparathyroidisms, Type Ia,Pseudohypoparathyroidisms, Type Ib,Type Ia Pseudohypoparathyroidism,Type Ia Pseudohypoparathyroidisms,Type Ib Pseudohypoparathyroidism,Type Ib Pseudohypoparathyroidisms
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
May 2003, The Journal of clinical endocrinology and metabolism,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
January 1986, Annales de medecine interne,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
December 1980, The Journal of clinical endocrinology and metabolism,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
March 1991, Acta paediatrica Scandinavica,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
September 2001, Journal of the American Society of Nephrology : JASN,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
December 1988, Irish journal of medical science,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
June 1994, Calcified tissue international,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
May 1979, The Journal of clinical endocrinology and metabolism,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
August 1985, The Journal of clinical endocrinology and metabolism,
N Loveridge, and J A Fischer, and C Nagant de Deuxchaisnes, and M A Dambacher, and F Tschopp, and E Werder, and J P Devogelaer, and R de Meyer, and L Bitensky, and J Chayen
June 1988, Clinical science (London, England : 1979),
Copied contents to your clipboard!